SCHEMBL14728264

SCHEMBL14728264

CC1(C)CCc2c(c(Cl)n3c(nc4ccccc43)c2C(N)=O)C1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 2/20 0.53
KDM4E B2RXH2 3/20 0.39
ALDH1A1 P00352 3/20 0.39
GAA P10253 1/20 0.39
HPGD P15428 1/20 0.37
CASP1 P29466 1/20 0.37
HSD17B10 Q99714 1/20 0.37
CACNA1G O43497 5/20 0.37
CACNA1H O95180 5/20 0.37
CACNA1I Q9P0X4 5/20 0.37
EEF2K O00418 3/20 0.36
PKMYT1 Q99640 1/20 0.36
PRF1 P14222 1/20 0.35
KCNH2 Q12809 1/20 0.35
CACNA1C Q13936 1/20 0.35
EPHB4 P54760 1/20 0.34
PDE4D Q08499 1/20 0.34
MAPT P10636 2/20 0.34
NPC1 O15118 1/20 0.34
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14716115 0.91 PDE4B (0.59) PDE4BKDM4EALDH1A1GAAHPGD
SCHEMBL14716459 0.83 KDM4E (0.44) PDE4BKDM4EALDH1A1GAAHPGD
SCHEMBL14716270 0.80 PDE4B (0.71) PDE4BKDM4EALDH1A1GAAHPGD
SCHEMBL14728269 0.79 PDE4B (0.40) PDE4BKDM4EALDH1A1GAAHPGD
SCHEMBL14728254 0.78 MAPT (0.52) KDM4EALDH1A1GAAHPGDCASP1
SCHEMBL14728644 0.78 PDE4B (0.59) PDE4BKDM4EALDH1A1GAAHPGD
SCHEMBL14728286 0.77 PDE4B (0.89) PDE4BKDM4EALDH1A1GAAHPGD
SCHEMBL14748488 0.77 MAPT (0.34) PDE4BKDM4EALDH1A1GAAHPGD
SCHEMBL14728640 0.72 PDE4B (0.70) PDE4BKDM4EALDH1A1GAAHPGD
SCHEMBL14728273 0.72 PDE4B (0.80) PDE4BKDM4EALDH1A1GAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8822688-B2 Imidazo[1,2-a]pyridine derivative ASTELLAS PHARMA INC. (JP) 2014-09-02 US disclosed
US-8822688-B2 Imidazo[1,2-a]pyridine derivative ASTELLAS PHARMA INC. (JP) 2014-09-02 US disclosed
US-20130053363-A1 IMIDAZO[1,2-a]PYRIDINE DERIVATIVE ASTELLAS PHARMA INC. (JP) 2013-02-28 US disclosed
US-20130053363-A1 IMIDAZO[1,2-a]PYRIDINE DERIVATIVE ASTELLAS PHARMA INC. (JP) 2013-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130053363-A1 IMIDAZO[1,2-a]PYRIDINE DERIVATIVE PDE4B, PDE4A, PDE4C PDE4B 1/4885KDM4E 586/4885ALDH1A1 1070/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.